SSRIs and Yohimbine
Supplement–drug interaction evidence from the TruthStack database.
| Severity | HIGH |
|---|---|
| Evidence Tier | Moderate |
| Interaction Type | PHARMACODYNAMIC RISK |
| Mechanism | PHARMACODYNAMIC |
| Last Reviewed | 2026-02-16 |
Summary
Yohimbine has alpha-2 antagonist and weak MAOI activity. Combined with SSRIs, literature flags increased serotonergic and cardiovascular effects. Monitor blood pressure and discuss with your prescriber or pharmacist.
API Reference
GET https://api.truthstack.co/v1/check?c1=SSRIs&c2=Yohimbine
Open, unauthenticated. Returns JSON. Developer documentation
Related Interactions
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.